JP Stock MarketDetailed Quotes
4594 BrightPath Biotherapeutics
- 53
- +2+3.92%
20min DelayMarket Closed Aug 9 15:00 JST
3.77BMarket Cap-2910P/E (Static)
56High51Low2.62MVolume53Open51Pre Close139.46MTurnover14852wk High3.68%Turnover Ratio71.14MShares4352wk Low-18.21EPS TTM3.77BFloat Cap2229Historical HighLossP/E (Static)71.14MShs Float43Historical Low-18.21EPS LYR9.80%Amplitude--Dividend TTM3.84P/B100Lot Size--Div YieldTTM
About BrightPath Biotherapeutics Company
BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.
Company Profile
Symbol4594
Company NameBrightPath Biotherapeutics
Founded2003-05-08
MarketTSE Growth
Fiscal Year Ends03-31
Address2-2-4 Kojimachi Kojimachi Central Building 7th Floor
Zip Code102-0083
Phone03-5840-7697
Websitewww.brightpathbio.com
Company Executives
- Name
- Position
- Salary
- Kenichi Nagai
- President, Chief Executive Officer and Director
- --
- Yoichi Takeshita
- Director and Chief Financial Officer
- --
- Norihiro Nakamura
- Director and Manager of Drug Discovery Research Department
- --
- Akira Yamada
- Director
- --
- Hirotaka Takeuchi
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
% Chg